Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LcrV is a multifunctional protein produced by Yersinia pestis, the bacterium responsible for plague. It regulates and facilitates the secretion and translocation of effector proteins (Yops) via the type III secretion system (T3SS). LcrV modulates host immune responses and is a potent protective antigen, making it a vaccine candidate.
Antibodies against LcrV confer protection against plague. The mechanism of protection does not necessarily block effector translocation but provides immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V virulence antigen of Yersinia pestis (LcrV).